{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-046079","form_type":"8-K","ticker":"RMTG","cik":"0001760026","company_name":"Regenerative Medical Technology Group Inc.","filed_at":"2024-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.936319+00:00","generated_at":"2026-06-01T09:17:11.618690+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Meso Numismatics reports positive operating cash flow >$100k in Q1 2024; proceeding with name change to RMTG","bullets":["Name change to Regenerative Medical Technology Group Inc. pending FINRA market effective date.","Positive cash from operations over $100k for the quarter ended March 31, 2024, per recent 10-Q.","New logo and authorized shares change near completion to reflect biotech focus.","Company transitions from numismatics to regenerative medicine, now a stem cell company."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-046079","json":"https://secwatch.observer/filing/0001213900-24-046079.json","markdown":"https://secwatch.observer/filing/0001213900-24-046079.md","text":"https://secwatch.observer/filing/0001213900-24-046079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760026/000121390024046079/0001213900-24-046079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760026/000121390024046079/ea0206745-8k_mesonum.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:17:11.618690+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}